Press "Enter" to skip to content

Global Prostate Cancer Diagnostics and Therapy Market 2021 analysis with Key Players, Applications, Trends and Forecasts

Prostate Cancer Diagnostics and Therapy

Prostate Cancer Diagnostics and Therapy Market” report provides strategic supports mentioned by the business specialists with market sources, amount of manufacturing cost structure, raw materials, forecasts, turnover, manufacturing outlays, latest market trends, labor cost, demands and much more. Prostate Cancer Diagnostics and Therapy market report covers a comprehensive market structure through the globe with an in-depth study of major dynamics (Drivers, Challenges, Opportunities).  

Request a sample copy of the report –

Key Market Trends:

The Prostate-specific Antigen (PSA) Testing Segment is Expected to Grow at Rapid Pace.

Prostate-specific Antigen (PSA) is a protein produced by prostate cells. Therefore, the PSA test is performed to diagnose prostate cancer (PCa) in men and for follow-up post treatment to check if the cancer relapses. PSA testing is an important tool for detecting prostate cancer, which measures the level of PSA in a man’s blood. Medicare and several private insurers provide coverage for an annual PSA test for all Medicare-eligible men aged 50 and older. The PSA testing is gaining popularity among clinicians and hospitals, owing to the increasing number of people being affected by prostate cancer. It has more market value in the countries with high prevalence rate (Western) and low prevalence rate (Asian), as PSA is used globally for the early detection/screening of prostate cancer.

PSA testing is anticipated to reduce the likelihood of death from prostate cancer. Refinements of the prostate-specific antigen (PSA) test have been developed to reduce the number of false positive results. Therefore, due to the rising prevalence of prostate cancer, the market is expected to witness high growth rate, over the forecast period.

is Expected to Retain the Largest Market Share During the Period of Forecast.

Prostate cancer is considered as one of the most common cancers among American men, and more than 60% of all prostate cancers are diagnosed in men older than 65. According to the American Cancer Society’s, 2019, there are about 174,650 new cases of prostate cancer accounting for 31,620 deaths. Hence, it is considered to have an early diagnosis of the condition. In case of the treatment, the early stages of prostate cancer are treated by radiation therapy and for the late stages, where it has spread beyond the prostate gland, hormone therapy, chemotherapy, and or immunotherapy treatments, are recommended. In the case of benign prostatic hyperplasia (BPH), resectoscopy is the major treatment procedure. Zytiga and Xtandi are the major therapeutics that are used for treatment. Zytiga is approved for the treatment of metastatic castration-resistant prostate cancer (mCRPC). With promising pipeline drugs, such as Apalutamide, the market of therapeutics is expected to increase.

Market Overview:

  • The prostate cancer diagnostics and therapy market is expected to register a CAGR of nearly 6.1% during the forecast period, 2019-2024.
  • – The major factor driving the growth of the market studied is aging population and high prevalence rate of prostate cancer. Prostate cancer is the second most common type of cancer in male population. About 80% of men who reach 80 years of age are diagnosed with it.
  • – As per the estimates provided by the American Cancer Society, in 2018, the is expected to witness over 164,690 new cases of prostate cancer, with over 29,430 related deaths. Nearly 60% of the total prostate cancer cases diagnosed are among men aged 65 years or older. One in every nine men is expected to be diagnosed with prostate cancer during his lifetime.
  • – In addition, according to the Census Bureau’s Statistics, the total number of people aged 65 and older exceeds 50 million as of 2017, and the number of elderly is projected to increase by almost 18 million during 2020-2030. The number of people aged 85 and older is expected to triple from an estimated 6 million of today to nearly 20 million, by 2060. The risk of developing prostate cancer increases significantly with age, and rise in geriatric population is one of the leading factors that contribute to the expansion of the mar

    Key Manufacturers Like 

  • Ipsen SA
  • Bayer AG
  • Astellas Pharma Inc.
  • Abbvie Inc.
  • Dendreon Pharmaceuticals LLC
  • AstraZeneca PLC
  • Sanofi
  • Aventis
  • Tolmar Inc.
  • Koninklijke Philips NV
  • Hologic Inc..

    Scope of the Report:

  • The prostate gland is located in the pelvis, below the bladder and in front of the rectum. Prostate cancer begins when normal cells in the prostate begin to multiply uncontrollably. The scope of the study is limited to revenue generated by various diagnostic and therapeutic products used in the management of benign prostatic hyperplasia, prostatic adenocarcinoma, and small cell carcinoma, among other types of prostate cancer.

    Prostate Cancer Diagnostics and Therapy market report focuses on the latest trends in the global and regional spaces on all the significant components, including the capacity, cost, price, technology, supplies, production, profit, and competition. Moreover, the old data and present development of the Prostate Cancer Diagnostics and Therapy market have been given in the scope of the report. The latest trends, product portfolio, demographics, geographical segmentation, and regulatory framework of the Prostate Cancer Diagnostics and Therapy market have also been involved in the study.

    Market Dynamics: –

    • Drivers: (Developing regions and growing markets)
    • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
    • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

    Inquire Or Share Your Questions If Any Before The Purchasing This Report –

    Key Questions Answered in Market Report: –

    • What will the market growth rate, Overview and Analysis by Type of Prostate Cancer Diagnostics and Therapy market in 2023?
    • What are the key factors driving, Analysis by Applications and Countries Prostate Cancer Diagnostics and Therapy market?
    • What are Dynamics, This Overview Includes Analysis of Scope, and price analysis of top Vendors Profiles of Prostate Cancer Diagnostics and Therapy ?
    • Who are Opportunities, Risk and Driving Force of Prostate Cancer Diagnostics and Therapy market? Knows Upstream Raw Materials Sourcing and Downstream Buyers
    • Who are the opportunities and threats faced by the vendors in Prostate Cancer Diagnostics and Therapy space? Business Overview by Type, Applications, Gross Margin and Market Share
    • What are the Prostate Cancer Diagnostics and Therapy market opportunities, market risk and market overview of the Market?

    Lastly, the Global Prostate Cancer Diagnostics and Therapy Market Research covers a complete market structure across the world with a comprehensive analysis of major key factors. This report provides planned orientations referred by the industry experts.

    Purchase This Report (Price 4250 USD for single user license) –   

    Study objectives of Prostate Cancer Diagnostics and Therapy Market Report:

    • To provide a detailed analysis of the market structure along with the Prostate Cancer Diagnostics and Therapy market forecast of various segments and sub-segments of the Prostate Cancer Diagnostics and Therapy market
    • To provide insights into factors influencing and affecting market growth
    • To provide historical, current, and forecast revenue of market segments based on material, type, design, and end user
    • To provide historical, current, and forecast revenue of market segments and sub-segments with respect to regional markets and key countries
    • To provide strategic profiling of key players in the market, comprehensively analyzing their market shares, core competencies, and drawing a competitive landscape for the market
    • To provide economic factors, technology and Prostate Cancer Diagnostics and Therapy market trends that influence the global Prostate Cancer Diagnostics and Therapy market

    Detailed TOC of Prostate Cancer Diagnostics and Therapy Market Report 2019-2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Rising Aging Population and High Prevalence Rate of Prostate Cancer
    4.2.2 Innovation in Drugs and Developments in Genomics and Proteomics
    4.2.3 Increasing Government Initiatives for Cancer Awareness
    4.3 Market Restraints
    4.3.1 High Cost of Prostate Cancer Drugs
    4.3.2 Low Success Rate of Clinical Trials
    4.4 Porter’s Five Force Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 By Type
    5.1.1 Benign Prostatic Hyperplasia
    5.1.2 Prostatic Adenocarcinoma
    5.1.3 Small Cell Carcinoma
    5.1.4 Other Types
    5.2 By Modality
    5.2.1 Diagnosis Tissue Biopsy Transrectal Ultrasound Clinical Laboratory Examination Prostate-specific Antigen Testing Urine Testing Diagnostic Imaging
    5.2.2 Treatment Surgery Radiation Therapy Therapeutics Hormone Therapy Chemotherapy Other Treatments
    5.3 Geography
    5.3.1 North America United States Canada Mexico
    5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
    5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.3.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Ipsen SA
    6.1.2 Bayer AG
    6.1.3 Astellas Pharma Inc.
    6.1.4 Abbvie Inc.
    6.1.5 Dendreon Pharmaceuticals LLC
    6.1.6 AstraZeneca PLC
    6.1.7 Sanofi-Aventis
    6.1.8 Tolmar Inc.
    6.1.9 Koninklijke Philips NV
    6.1.10 Hologic Inc.


    Purchase This Report (Price 4250 USD for single user license) –


    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other report :
    Liquid Filling Capping Machines Market 2021: Leading Company Analysis, Share, Growth, Size, Opportunities, Trends, Regional Overview, and Key Country Forecast to 2027

    Tall Oil Fatty Acid Market 2021 Growth Analysis, Share, Demand by Regions, Types and Analysis of Key Players- Research Forecasts To 2027

    Global Striked String Instrument Market Overview, Cost Structure Analysis, Growth Opportunities and Forecast to 2026

    Lighting Innovations Market 2021: Global Companies, Consumption, Drivers, Trends, Forces Analysis, Revenue, Challenges, Top Leading Countries and Global Forecast 2027

    Cereal Bars Market 2021 Analysis, Growth by Top Companies, Trends by Types and Application, Forecast Analysis To 2027

    Global Industrial Brakes Market 2021: Market Size, Share, Growth, Sales and Drivers Analysis Research Report 2027 with COVID-19 Impact

    Global Dissecting Microscopes Market 2021 Outlook to 2027: Top Companies in Market, Trends & Growth Factors and Details for Business Development

    Global Commercial Vehicle Aluminum Alloy Wheel Market 2021 Analysis by Current Industry Status & Growth Opportunities, Top Key Players, Target Audience and Forecast to 2027

    Process Signal Conditioners Market – Global Industry Analysis, Growth, Size, Share, Trends and Estimate by 2021 – 2027

    Magnetic Heating Agitator Market 2021 – Segmented by Application and Geography Trends, Growth and Forecasts to 2027

    Home Audio Speakers Market Development, Market Trends, Key Driven Factors, Segmentation and Forecast to 2027

    All-wheel Steer Loaders Market Research Report 2021: Growth Opportunities, Challenges, Statistics, Size, Share, Restraints, Drivers with Key Player Analysis till 2027